Previous research revealed that the PDK1/AKT/Caspase 3 pathway is the mechanism through which lncRNA-PDPK2P promotes the development of hepatocellular carcinoma (Pan et al., 2019). Here, AKT1 is linked to hepatocellular carcinoma.